The protein map is “the first to apply quantitative proteomics to imaging,” said Richard D. Smith, Battelle Fellow at the Department of Energy’s Pacific Northwest National Laboratory, who led the mapping effort with Desmond Smith of UCLA’s David Geffen School of Medicine.
“Proteins are the lead actors, the most important part of the picture,” PNNL’s Smith said. “They are the molecules that do the work of the cells.”
Fine-tuning such proteome maps will enable comparisons of healthy brains with others whose protein portraits look different. Contrasts in location and abundance of proteins may display the earliest detectable stages of Alzheimer’s, Parkinson’s and other neurological diseases. They hope such diseases might be curbed if caught and treated early enough.
The National Institutes of Health-funded study, performed at DOE’s Environmental Molecular Sciences Laboratory on PNNL’s campus, is published in the advance online edition of Genome Research and featured in current Nature online Neuroscience Gateway (
http://www.brainatlas.org). PNNL staff scientists Vladislav A. Petyuk, Wei-Jun Qian and UCLA’s Mark Chin are co-lead authors.
To produce the map, the team characterized center-brain slices as several dozen 1 millimeter cubes, or “voxels,” to “show us where proteins appear in the brain and where they vary in abundance,” PNNL’s Smith said. “We labeled all the proteins so we would have reference points so we know we’re looking at the same protein between different parts of the brain and from one mouse to another.”
Until now, proteomics, which enlists a specially modified instrument called a mass spectrometer for the task of identifying proteins and tallying them, has been akin to flying blind over a lake of proteins. The abundance and protein type could be discerned from a given sample, but “knowing their location and how the abundances change in different cases is important for understanding what they do,” PNNL’s Smith said.
He said that variations in genomic material across the slice, specifically messenger RNA, from the Allen Brain Atlas should be similar to the observed proteome. This turned out to be the case, which helped to validate the new measurements.
“What the Allen Brain Atlas doesn’t tell you is which genes produce proteins and how much of each of them,” he said. Marrying the voxel map with proteomics, researchers were able to generate “quantitative information on close to 1,200 different proteins.”
Source: Pacific Northwest National Laboratory
Related stories:
A second career for a growth factor receptor: keeping nerve axons on target
Neurons constituting the optic nerve wire up to the brain in a highly dynamic way. Cell bodies in the developing retina sprout processes, called axons, which extend toward visual centers in the brain, lured by attractive cues and making U-turns when they take the wrong path. How they find targets so accurately is a central question of neuroscience today.
Researchers catch ion channels in their opening act
Each thought or action sends a million electrical signals pulsing through your body. At the heart of the process of generating these electrical impulses is the ion channel.
Fluorescent-Probe in Worm Creates Real-Time 'View' of Cellular Stress
Scientists at the University at Buffalo have created a mutant worm that changes color when it moves.
Researchers map signaling networks that control neuron function
In the first large-scale proteomics study of its kind, researchers at the University of California, San Diego School of Medicine have mapped thousands of neuronal proteins to discover how they connect into complex signaling networks that guide neuron function. Their research – using quantitative mass spectrometry, computational software and bioinformatics to match the proteins to their cellular functions – may lead to a better understanding of brain development, neurodegenerative diseases, and spinal cord regeneration.
Worth a thousand words: Hopkins researchers paint picture of cancer-promoting culprit
They say that a picture can be worth a thousand words. This especially is true for describing the structures of molecules that function to promote cancer. Researchers at Johns Hopkins have built a three-dimensional picture of an enzyme often mutated in many types of cancers. The results, published Dec. 14 in Science, suggest how the most common mutations in this enzyme might lead to cancer progression.
Scientists create colorful 'brainbow' images of the nervous system
By activating multiple fluorescent proteins in neurons, neuroscientists at Harvard University are imaging the brain and nervous system as never before, rendering their cells in a riotous spray of colors dubbed a "Brainbow."
Research could lead to treatment for Alzheimer's disease
A molecule designed by a Purdue University researcher could lead to the first drug treatment for Alzheimer's disease.
Researchers hot on the trail of brain cell degeneration
A research team headed by Academy Research Fellow Michael Courtney has identified a new molecular pathway in neurons. The pathway is a factor in the degeneration of brain cells, which in turn plays an important role in neurological conditions and diseases, such as Alzheimer's disease, epilepsy and stroke.
